Sanofi | SNY - Capital Ordinário





Capital Ordinário Alterar Data
AbbVie USD 1.77B 1.75B 2025-06
Amgen USD 540M 1000K 2026-03
AstraZeneca USD 1.55B 73K 2026-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 368.28M 35.9M 2025-12
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Drreddys Laboratories INR 832.57M 53K 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
Galapagos EUR 65.9M 0 2026-03
Genmab DKK 61.62M 52K 2025-12
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Glaxosmithkline GBP 4.08B 49.43M 2025-12
J&J USD 2.41B 1.74M 2025-12
Merck USD 2.47B 12.72M 2025-12
Novartis USD 1.91B 60K 2026-03
Novartis USD 1.91B 10.64M 2025-12
Pacira USD 39.31M 1.81M 2026-03
Perrigo USD 138.1M 500K 2026-03
Pfizer USD 5.7B 13M 2026-03
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 47.32M 765K 2025-12
Roche Holding CHF 795.62M 699.54K 2025-12
Sanofi EUR 1.21B 8.25M 2026-03
Supernus Pharmaceuticals USD 58.04M 582K 2026-03
UCB EUR 190.36M 365.15K 2025-12
Zoetis USD 420.35M 4.58M 2026-03